ReviewResearch (Washington, D.C.)2025
Deciphering Key Regulatory Roles of Linear Ubiquitination in Cell Fate Determination and Disease.
Review in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- USP5 in cancer: a therapeutic window into metabolism and drug resistance.Journal of translational medicine · 2026Review
- CDK2-Mediated Phosphorylation ofResearch (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell fate determination is a complex and dynamic process. Across diverse cellular contexts, various protein modifications (PTMs) are involved throughout the entire process of cell fate determination. Linear ubiquitination is a specific type of PTM. Under the catalysis of linear ubiquitin chain assembly complex, multiple ubiquitin molecules form a unique linear ubiquitin chain and modify the substrate. A growing number of studies have shown that linear ubiquitination is an important regulatory target in the cell fate determination pathway, and that once the linear ubiquitination process of key proteins is defective, the cell fate determination process will be disrupted and lead to the development of various diseases. In this review, we systematically elaborated the key links between linear ubiquitination and cell fate determination from the aspects of cell proliferation, differentiation, senescence, and survival/death. Furthermore, we provide an in-depth exploration of the molecular mechanisms through which homeostatic imbalance of linear ubiquitination contributes to numerous diseases, including neoplastic, neurodegenerative, infectious, inflammatory, and metabolic disorders. Finally, we fully affirm the significance of linear ubiquitination as a promising therapeutic target for future drug discovery and development. Our critical appraisal and synthesis of the literature provide a foundational framework for future investigations and inform novel strategies for the treatment and management of related diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.